Therapeutic evaluation of the unani formulation in management of warm tajaweef-e- anaf muzmin -A randomised open study with placebo
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
- 试验地点
- 1
- 主要终点
- improvement in Objective parameters
研究概览
简要总结
Chronic sinusitis is characterised by nasal discharge ,obstruction,sneezing,headche which often necetitates the patients to undergo modern interventions such as use of anti histaminics, analgesics for long term use and later on surgical intervention. Under such circumstances ,unani system boasts to have a treasure of safe and effective unani drugs with minimal side effects.In order to reduce the cost of management of chronic sinusitis in all aspects and reduce the side effects of modern medicines,this trial consisting of decoction of gul e banafsha,barg e gaozaban,tukhme khatmi,tukhme khubbazi,unnab has been designed to evaluate the efficacy of nuskha joshanda nazla barid in patients of chronic sinusitis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Random Number Table
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 20.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Clinically diagnosed patients of chronic sinusitis through objective parameters[Assessment of opacity and Assessment of mucosal thickening by xray pns w/v] and subjective parameters[
- •Nasal Obstruction
- •Nasal discharge
- •Headache 5.Post nasal drip 6.Abnormalites of smell 7.Heaviness in head
- •Tenderness of sinuses] Patients of both sexes.
- •Patients in the age group of 20 to 60 years.
- •Those who give written consent.
排除标准
- •Patients below 20 years of age.
- •Patients above 60 years of age.
- •Pregnant & lactating mothers.
- •Patients who fail to give consent.
- •Patients who fail to follow up.
- •Mentally retarded persons.
- •â€¢Patients of diabetes mellitus or any comorbid disease.
- •â€¢Malignancy of nose and paranasal sinuses.
- •â€¢Patients having any history of trauma to nose or sinus area, any surgery of nose or paranasal sinuses.
- •â€¢Patients having any congenital and acquired structural abnormality of the nasal cavity.
- •â€¢Any medical condition where physician feels that participation in the study could be detrimental to patient well being.
结局指标
主要结局
improvement in Objective parameters
时间窗: 45 days with basline and after completion.
opacity
时间窗: 45 days with basline and after completion.
Assessment of
时间窗: 45 days with basline and after completion.
mucosal
时间窗: 45 days with basline and after completion.
thickening through arbitary grading
时间窗: 45 days with basline and after completion.
次要结局
- improvement in Subjective parameters(1. Nasal Obstruction)